Loading…
The Obesity Epidemic and Its Impact on Hypertension
Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associa...
Saved in:
Published in: | Canadian journal of cardiology 2012-05, Vol.28 (3), p.326-333 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3 |
---|---|
cites | cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3 |
container_end_page | 333 |
container_issue | 3 |
container_start_page | 326 |
container_title | Canadian journal of cardiology |
container_volume | 28 |
creator | Nguyen, Thang, MD, FRCPC Lau, David C.W., MD, PhD, FRCPC |
description | Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern. |
doi_str_mv | 10.1016/j.cjca.2012.01.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1015093744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X12000025</els_id><sourcerecordid>1015093744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</originalsourceid><addsrcrecordid>eNp9kU1L5TAUhoOM6PXqH5jF0OVsWk_SpGlBBgZR7wXBhQruQm5yiun0y6QduP9-Uq7jwoXZnEWe94XzHEK-U8go0OKyyUxjdMaAsgxoBkCPyIpWtEglSPGNrKBkZcpK9nJKzkJoADiVsjghp4yJSnBerkj-9IrJww6Dm_bJzegsds4kurfJdgrJthu1mZKhTzb7Ef2EfXBDf06Oa90GvHifa_J8e_N0vUnvH-6217_vU8OlnNIil7WWGmvKoWICyh1ynUtuRc6tlXYnRF6XUMd_qrHSssi1BUsrMKIoEPM1-XnoHf3wNmOYVOeCwbbVPQ5zUFGCgCo28oiyA2r8EILHWo3eddrvI7RwhWrUIkstshRQFWXF0I_3_nnXof2I_LcTgasDgHHLvw69CsZhb9A6j2ZSdnBf9__6FDet653R7R_cY2iG2ffRn6IqxIx6XM61XIsyiI-J_B99Go34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015093744</pqid></control><display><type>article</type><title>The Obesity Epidemic and Its Impact on Hypertension</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</creator><creatorcontrib>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><description>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2012.01.001</identifier><identifier>PMID: 22595448</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Antihypertensive Agents - therapeutic use ; Attitude to Health ; Bariatric Surgery - methods ; Behavior Therapy - methods ; Body Mass Index ; Cardiovascular ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - therapy ; Child ; Combined Modality Therapy ; Comorbidity ; Female ; Humans ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - epidemiology ; Life Style ; Male ; Middle Aged ; Obesity - diagnosis ; Obesity - epidemiology ; Obesity - therapy ; Obesity, Morbid - diagnosis ; Obesity, Morbid - epidemiology ; Obesity, Morbid - therapy ; Prevalence ; Prognosis ; Risk Assessment ; Sex Distribution ; Treatment Outcome ; Young Adult</subject><ispartof>Canadian journal of cardiology, 2012-05, Vol.28 (3), p.326-333</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2012 Canadian Cardiovascular Society</rights><rights>Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</citedby><cites>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22595448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Thang, MD, FRCPC</creatorcontrib><creatorcontrib>Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><title>The Obesity Epidemic and Its Impact on Hypertension</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Attitude to Health</subject><subject>Bariatric Surgery - methods</subject><subject>Behavior Therapy - methods</subject><subject>Body Mass Index</subject><subject>Cardiovascular</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - therapy</subject><subject>Child</subject><subject>Combined Modality Therapy</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Life Style</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity - diagnosis</subject><subject>Obesity - epidemiology</subject><subject>Obesity - therapy</subject><subject>Obesity, Morbid - diagnosis</subject><subject>Obesity, Morbid - epidemiology</subject><subject>Obesity, Morbid - therapy</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Sex Distribution</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kU1L5TAUhoOM6PXqH5jF0OVsWk_SpGlBBgZR7wXBhQruQm5yiun0y6QduP9-Uq7jwoXZnEWe94XzHEK-U8go0OKyyUxjdMaAsgxoBkCPyIpWtEglSPGNrKBkZcpK9nJKzkJoADiVsjghp4yJSnBerkj-9IrJww6Dm_bJzegsds4kurfJdgrJthu1mZKhTzb7Ef2EfXBDf06Oa90GvHifa_J8e_N0vUnvH-6217_vU8OlnNIil7WWGmvKoWICyh1ynUtuRc6tlXYnRF6XUMd_qrHSssi1BUsrMKIoEPM1-XnoHf3wNmOYVOeCwbbVPQ5zUFGCgCo28oiyA2r8EILHWo3eddrvI7RwhWrUIkstshRQFWXF0I_3_nnXof2I_LcTgasDgHHLvw69CsZhb9A6j2ZSdnBf9__6FDet653R7R_cY2iG2ffRn6IqxIx6XM61XIsyiI-J_B99Go34</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Nguyen, Thang, MD, FRCPC</creator><creator>Lau, David C.W., MD, PhD, FRCPC</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120501</creationdate><title>The Obesity Epidemic and Its Impact on Hypertension</title><author>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Attitude to Health</topic><topic>Bariatric Surgery - methods</topic><topic>Behavior Therapy - methods</topic><topic>Body Mass Index</topic><topic>Cardiovascular</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - therapy</topic><topic>Child</topic><topic>Combined Modality Therapy</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Life Style</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity - diagnosis</topic><topic>Obesity - epidemiology</topic><topic>Obesity - therapy</topic><topic>Obesity, Morbid - diagnosis</topic><topic>Obesity, Morbid - epidemiology</topic><topic>Obesity, Morbid - therapy</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Sex Distribution</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Thang, MD, FRCPC</creatorcontrib><creatorcontrib>Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Thang, MD, FRCPC</au><au>Lau, David C.W., MD, PhD, FRCPC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Obesity Epidemic and Its Impact on Hypertension</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>28</volume><issue>3</issue><spage>326</spage><epage>333</epage><pages>326-333</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>22595448</pmid><doi>10.1016/j.cjca.2012.01.001</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0828-282X |
ispartof | Canadian journal of cardiology, 2012-05, Vol.28 (3), p.326-333 |
issn | 0828-282X 1916-7075 |
language | eng |
recordid | cdi_proquest_miscellaneous_1015093744 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adolescent Adult Age Distribution Aged Antihypertensive Agents - therapeutic use Attitude to Health Bariatric Surgery - methods Behavior Therapy - methods Body Mass Index Cardiovascular Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - therapy Child Combined Modality Therapy Comorbidity Female Humans Hypertension - diagnosis Hypertension - drug therapy Hypertension - epidemiology Life Style Male Middle Aged Obesity - diagnosis Obesity - epidemiology Obesity - therapy Obesity, Morbid - diagnosis Obesity, Morbid - epidemiology Obesity, Morbid - therapy Prevalence Prognosis Risk Assessment Sex Distribution Treatment Outcome Young Adult |
title | The Obesity Epidemic and Its Impact on Hypertension |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A26%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Obesity%20Epidemic%20and%20Its%20Impact%20on%20Hypertension&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Nguyen,%20Thang,%20MD,%20FRCPC&rft.date=2012-05-01&rft.volume=28&rft.issue=3&rft.spage=326&rft.epage=333&rft.pages=326-333&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2012.01.001&rft_dat=%3Cproquest_cross%3E1015093744%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1015093744&rft_id=info:pmid/22595448&rfr_iscdi=true |